MedPath

Biodistribution of [11C]laniquidar in healthy volunteers.

Conditions
biodistribution, dosimetry, healthy volunteers
Registration Number
NL-OMON25649
Lead Sponsor
VU University Medical Center
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
6
Inclusion Criteria

1. Age between 18-65 years;

2. Good physical health evaluated by medical history, physical (including neurological) examination and screening laboratory tests;

Exclusion Criteria

1. Any clinical significant abnormality of any clinical laboratory test;

2. Any subject who has received any investigational medication within 30 days prior to the start of this study, or who is scheduled to receive an investigational drug;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Biodistribution and dosimetry of [11C]Laniquidar in healthy volunteers.
Secondary Outcome Measures
NameTimeMethod
Metabolic profile of [11C]Laniquidar in humans.
© Copyright 2025. All Rights Reserved by MedPath